Neogenomics Inc (NEO)

EBITDA Growth

168.13%

Quarterly · Period ending:

NEO logo

NEO EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported168.13%
NEO Quarterly EBITDA YoY % (-53.79% → 168.13%)
High-resolution chart · PNG

NEO ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neogenomics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-53.7871%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.